Also trades as: SHL.DE (XETRA) · $vol 42M · 0PMJ.L (LSE) · $vol 17M · SMMNY (OTC) · $vol 2M

$44.19

+0.69 (+1.59%)

Weekly Expected Move ±5.0%

$40 $42 $44 $46 $49

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 44 · $49.5B mcap · 267M float · 0.0019% daily turnover · Short 43% of daily vol

Revenue

$23.4B +4.7% ▲

5Y CAGR: +10.1%

Gross Profit

$9.0B +6.8% ▲

5Y CAGR: +10.1%

Operating Income

$3.4B +4.3% ▲

5Y CAGR: +11.0%

Net Income

$2.1B +10.6% ▲

5Y CAGR: +8.8%

EPS (Diluted)

$1.91 +10.4% ▲

5Y CAGR: +6.3%

EBITDA

$4.6B +8.7% ▲

5Y CAGR: +10.1%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$18.0B	$21.7B	$21.7B	$22.4B	$23.4B
YoY Growth	+24.5%	+20.7%	-0.2%	+3.2%	+4.7%
Cost of Revenue	$11.0B	$13.6B	$14.0B	$13.9B	$14.4B
Gross Profit	$7.0B	$8.1B	$7.7B	$8.5B	$9.0B
Gross Margin	38.6%	37.5%	35.6%	37.9%	38.6%
R&D Expenses	$1.5B	$1.8B	$1.9B	$1.9B	$2.0B
SG&A Expenses	$2.6B	$3.3B	$3.4B	$3.2B	$3.6B
Operating Expenses	$4.2B	$5.1B	$5.3B	$5.2B	$5.6B
Operating Income	$2.8B	$3.1B	$2.4B	$3.3B	$3.4B
Operating Margin	15.4%	14.1%	11.3%	14.8%	14.7%
Interest Expense	$83M	$118M	$296M	$476M	$426M
Income Before Tax	$2.4B	$2.8B	$1.9B	$2.5B	$2.9B
Tax Expense	$658M	$746M	$403M	$564M	$686M
Net Income	$1.7B	$2.0B	$1.5B	$1.9B	$2.1B
Net Margin	9.6%	9.4%	7.0%	8.7%	9.2%
EPS (Diluted)	$1.56	$1.81	$1.34	$1.73	$1.91
EBITDA	$3.5B	$4.3B	$3.8B	$4.2B	$4.6B
Shares Outstanding	1.10B	1.13B	1.12B	1.12B	1.12B

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$6.3B	$5.5B	$5.9B	$5.7B	$8.9B	$5.4B	$5.7B	$5.8B
Cost of Revenue	$3.9B	$3.3B	$3.6B	$3.5B	$5.5B	$3.3B	$3.6B	$3.3B
Gross Profit	$2.4B	$2.2B	$2.3B	$2.2B	$3.4B	$2.1B	$2.1B	$2.4B
Gross Margin	38.0%	39.3%	39.3%	38.5%	38.0%	38.4%	37.7%	42.5%
R&D Expenses	$496M	$481M	$485M	$493M	$500M	$476M	$489M	$487M
SG&A Expenses	$635M	$940M	$943M	$947M	$939M	$876M	$901M	$939M
Operating Expenses	$1.1B	$1.4B	$1.4B	$1.3B	$2.1B	$1.4B	$1.4B	$1.4B
Operating Income	$1.3B	$731M	$895M	$872M	$940M	$724M	$758M	$1.0B
Operating Margin	20.2%	13.3%	15.1%	15.4%	10.6%	13.4%	13.3%	17.7%
Interest Expense	$142M	$108M	$104M	$104M	$156M	$96M	$100M	$103M
Income Before Tax	$844M	$617M	$730M	$736M	$775M	$603M	$646M	$876M
Tax Expense	$220M	$139M	$193M	$180M	$173M	$147M	$133M	$201M
Net Income	$616M	$474M	$530M	$552M	$589M	$450M	$508M	$668M
Net Margin	9.7%	8.6%	9.0%	9.7%	6.6%	8.3%	8.9%	11.6%
EPS (Diluted)	$0.55	$0.42	$0.47	$0.49	$0.53	$0.40	$0.45	$0.59
EBITDA	$1.3B	$1.0B	$1.1B	$1.2B	$1.2B	$998M	$1.0B	$1.3B
Shares Outstanding	1.12B	1.13B	1.13B	1.13B	1.12B	1.12B	1.12B	1.12B

SEMHF OTC